Analysts Set National Health Investors, Inc. (NYSE:NHI) Price Target at $83.86

National Health Investors, Inc. (NYSE:NHI) has been assigned a consensus rating of “Moderate Buy” from the eight ratings firms that are presently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating and five have assigned a buy rating to the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $83.8571.

A number of equities analysts have recently weighed in on NHI shares. Weiss Ratings lowered National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, June 12th. Truist Financial reduced their price target on National Health Investors from $89.00 to $81.00 and set a “buy” rating for the company in a research note on Friday, June 12th. Zacks Research lowered National Health Investors from a “hold” rating to a “strong sell” rating in a report on Thursday, June 25th. BMO Capital Markets lowered their price objective on National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a research report on Monday, June 15th. Finally, Wells Fargo & Company dropped their target price on National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a report on Monday, June 1st.

National Health Investors Trading Up 0.7%

Shares of NHI stock opened at $80.49 on Monday. The firm has a 50 day moving average price of $75.02 and a two-hundred day moving average price of $79.72. The company has a quick ratio of 8.20, a current ratio of 8.20 and a debt-to-equity ratio of 0.83. The company has a market capitalization of $3.90 billion, a PE ratio of 25.96, a price-to-earnings-growth ratio of 3.59 and a beta of 0.51. National Health Investors has a 12-month low of $67.94 and a 12-month high of $91.38.

National Health Investors Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Tuesday, June 30th will be given a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a dividend yield of 4.6%. The ex-dividend date is Tuesday, June 30th. National Health Investors’s payout ratio is presently 118.71%.

Insider Activity at National Health Investors

In related news, Director Robert A. Mccabe, Jr. acquired 890 shares of the stock in a transaction on Monday, June 15th. The shares were purchased at an average price of $71.65 per share, for a total transaction of $63,768.50. Following the purchase, the director directly owned 44,159 shares in the company, valued at approximately $3,163,992.35. The trade was a 2.06% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO D. Eric Mendelsohn acquired 1,500 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The shares were acquired at an average price of $68.84 per share, with a total value of $103,260.00. Following the completion of the transaction, the chief executive officer owned 133,316 shares in the company, valued at $9,177,473.44. The trade was a 1.14% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders own 2.70% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. State Street Corp grew its position in shares of National Health Investors by 5.0% during the 2nd quarter. State Street Corp now owns 2,023,381 shares of the real estate investment trust’s stock worth $143,651,000 after buying an additional 95,812 shares during the period. Principal Financial Group Inc. increased its stake in National Health Investors by 2.0% in the first quarter. Principal Financial Group Inc. now owns 1,700,908 shares of the real estate investment trust’s stock valued at $137,537,000 after purchasing an additional 32,902 shares in the last quarter. Geode Capital Management LLC increased its stake in National Health Investors by 1.5% in the fourth quarter. Geode Capital Management LLC now owns 1,262,657 shares of the real estate investment trust’s stock valued at $96,443,000 after purchasing an additional 18,198 shares in the last quarter. Centersquare Investment Management LLC raised its holdings in shares of National Health Investors by 17.0% during the fourth quarter. Centersquare Investment Management LLC now owns 1,154,060 shares of the real estate investment trust’s stock valued at $88,136,000 after purchasing an additional 167,352 shares during the period. Finally, Bank of America Corp DE raised its holdings in shares of National Health Investors by 20.0% during the first quarter. Bank of America Corp DE now owns 992,802 shares of the real estate investment trust’s stock valued at $80,278,000 after purchasing an additional 165,467 shares during the period. Institutional investors and hedge funds own 62.51% of the company’s stock.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.